A Case of Bortezomib-Associated Thrombotic Microangiopathy in a Multiple Myeloma Patient

Bortezomib is a first-generation proteasome inhibitor used in the treatment of multiple myeloma. We present a case of a 70-year-old woman with multiple myeloma, who presented thrombotic microangiopathy with multi-organ involvement thrombotic microangiopathy (ocular, cardiac, and renal) after bortezo...

Full description

Bibliographic Details
Main Author: Moreira Fonseca, N (author)
Other Authors: Cardoso, F (author), Monteiro, M (author), Góis, M (author), Sousa, H (author), Fidalgo, T (author), Calado, J (author), Nolasco, F (author)
Format: article
Language:eng
Published: 2021
Subjects:
HCC NEF
CHLC MED
Bortezomib
Thrombotic Microangiopathies
Multiple Myeloma
Toxicity
Online Access:http://hdl.handle.net/10400.17/3867
Country:Portugal
Oai:oai:repositorio.chlc.min-saude.pt:10400.17/3867

Internet

http://hdl.handle.net/10400.17/3867

Similar Items